INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

An expert overview of the literature, useful as background reading.

523 studies · page 4 of 22

2019 / Narrative review

Foods fortified with 2-3 g/day of plant sterols or stanols lower LDL-cholesterol by 9-12% across various clinical settings.

This review summarizes evidence on plant sterol and stanol (PS) fortified foods for managing hypercholesterolemia. Meta-analyses of over 100 controlled clinical trials demonstrate that 2-3 g per day of PS yields a 9-12% reduction in LDL-cholesterol. In patients taking statins, the average LDL reduction with PS equals up-titrating the statin dose twice. A key limitation noted is the current lack of clinical trials evaluating the effects of PS on cardiovascular events.

Cofán M, Ros E Curr Med Chem, 2019. PMID 29984649

2019 / Narrative review

A review reports that about 130 human clinical trials of resveratrol have yielded varying results, alongside a pristine safety profile.

This narrative review discusses the history and development of resveratrol research. Around 130 human clinical trials have been conducted or are underway with varying results, potentially due to disparate doses ranging from approximately 5 to 5,000 mg/day and variable experimental settings. Molecular targets are numerous without a dominant mechanism, but resveratrol maintains a pristine safety profile and widespread use as a dietary supplement. The author suggests future investigation is warranted, noting potential promise for topical preparations and conditions responsive to anti-inflammatory action or direct exposure, such as colon cancer prevention.

Pezzuto JM Biomol Ther (Seoul), 2019. PMID 30332889

2019 / Narrative review of two prospective cohort studies

In AHS-2 and EPIC-Oxford cohorts, vegetarian diets were linked to lower cancer and mortality risks and substantially reduced greenhouse gas emissions.

Researchers reviewed publications from the AHS-2 and EPIC-Oxford cohorts to describe the dietary intakes, health effects, and environmental outcomes of vegetarian patterns. In AHS-2, vegans had a 16% reduced risk of all cancers, while vegans, vegetarians, and fish-eaters in EPIC-Oxford showed an 11-19% lower risk compared to non-vegetarians. Pesco-vegetarians in AHS-2 had significantly lower all-cause and ischemic heart disease mortality, and EPIC-Oxford fish-eaters had significantly lower all-cancer mortality versus non-vegetarians. Greenhouse gas emissions of equicaloric diets were 29% lower for vegetarian diets in AHS-2 and 47-60% lower for vegetarian/vegan diets in EPIC-Oxford compared to non-vegetarian/meat-eating diets.

Shows an association, not proof of cause and effect.

Segovia-Siapco G, Sabaté J Eur J Clin Nutr, 2019. PMID 30487555

2019 / Narrative review

A review suggests plant-based diets may offer cardiovascular safety and performance advantages for endurance athletes.

This review examined the role of plant-based diets in addressing cardiovascular risks and performance in endurance athletes, who studies suggest face higher-than-average risk for atherosclerosis and myocardial damage. The effect of plant-based diets on risk factors such as plasma lipids, body weight, blood pressure, and reversing existing atherosclerotic lesions may provide substantial cardiovascular protection. Furthermore, plant-based diets have consistently been shown to reduce body fat and indicators of inflammation, foster glycogen storage, and help reduce oxidative stress. By reducing blood viscosity and improving arterial flexibility and endothelial function, they may be expected to improve vascular flow and tissue oxygenation.

Barnard ND, Goldman DM, Loomis JF, et al. Nutrients, 2019. PMID 30634559

2019 / Clinical review of clinical trials

A review of 77 clinical studies highlights the lipid-lowering and insulin-resistance improving effects of berberine with low toxicity.

This review examined clinical trials on Berberis vulgaris and its alkaloid constituent berberine across electronic databases. Across 77 human clinical studies, lipid-lowering and insulin-resistance improving actions were the most frequently studied properties, alongside cardiovascular, anticancer, gastrointestinal, CNS, and endocrine applications. Berberine demonstrated very low toxicity at usual doses with no major side effects, though mild gastrointestinal reactions occurred in some patients.

Imenshahidi M, Hosseinzadeh H Phytother Res, 2019. PMID 30637820

2019 / Narrative review

Meeting or exceeding recommended physical activity levels supports longevity, with maximal benefits seen at three to five times the minimum recommendations.

This review examined recent evidence regarding the dose and type of physical activity that promotes longevity and disease-free aging. Meeting at least 150 minutes per week of moderate-intensity leisure time aerobic activity provides most longevity benefits, while higher duration and intensity augment cardiovascular and metabolic effects. Performing three to five times the minimum recommended physical activity achieves maximal longevity benefit, though benefit may decrease with even higher amounts. High maximal oxygen uptake in mid-life serves as a strong marker of longevity, and muscle mass is a critical prognostic factor in aging and cancer.

Pedersen BK Curr Opin Clin Nutr Metab Care, 2019. PMID 30640736

2019 / Narrative review of clinical trials

Resveratrol shows therapeutic potential across various diseases in over 244 clinical trials and is reported safe at doses up to 5 g/day.

This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.

Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437

2019 / Narrative review

Plant sterols and stanols may exert broader physiological and clinical effects beyond lowering low-density lipoprotein cholesterol.

This review evaluates potential biological roles and health effects of plant sterols and stanols beyond their known inhibition of intestinal cholesterol absorption and LDL lowering. The authors examine impacts ranging from intrauterine presence and breast milk to conditions such as non-alcoholic steatohepatitis, cardiovascular disease, inflammatory bowel diseases, and allergic asthma. Effects also appear to depend on the route of administration, as seen in intestinal-failure associated liver disease during parenteral nutrition. The authors emphasize a need to systematically understand the broader health effects of these compounds.

Plat J, Baumgartner S, Vanmierlo T, et al. Prog Lipid Res, 2019. PMID 30822462

2019 / Narrative review

Plant-based diets rich in healthy plant foods are linked to lower CVD risk, whereas less healthy plant foods are associated with increased risk.

This review evaluates definitions of plant-based diets and summarizes their associations with cardiovascular disease risk, distinguishing between healthy and less healthy plant foods. Studies show that plant-based diets with higher intakes of healthy foods such as whole grains, fruits, vegetables, nuts, legumes, oils, tea, and coffee are linked to lower CVD risk. Conversely, plant-based diets high in less healthy plant foods like refined grains, potatoes/fries, and foods/beverages high in added sugar are linked to higher risk. The authors note that plant-based diets need not completely exclude meat or animal products to confer cardiovascular benefits.

Shows an association, not proof of cause and effect.

Hemler EC, Hu FB Curr Atheroscler Rep, 2019. PMID 30895476

2019 / Narrative review

High dietary salt adversely affects target organs including the heart, kidneys, brain, and bone, irrespective of blood pressure.

This review evaluates the blood pressure-independent physiological effects of dietary salt and controversies surrounding lower salt intakes and cardiovascular outcomes. High dietary salt has been shown to adversely affect the vasculature, heart, kidneys, skin, brain, and bone, mediated commonly by heightened inflammation and oxidative stress. The review also addresses the role of background diet in modulating the effects of salt.

Robinson AT, Edwards DG, Farquhar WB Curr Hypertens Rep, 2019. PMID 31025198

2019 / Case report and literature review

A whole food plant-based diet alongside medical therapy was followed by weight loss and normalized heart function in a patient with heart failure.

A 54-year-old female presenting with grade 3 obesity (BMI 45.2 kg/m2), type II diabetes (A1c 8.1%), and heart failure with depressed left ventricular systolic function transitioned to a whole food plant-based diet alongside guideline-directed medical therapy. Over five and a half months, she lost 22.7 kg, reversed her diabetes without diabetes medications, and normalized her left ventricular systolic function. The authors noted that causality cannot be determined from this case report.

Allen KE, Gumber D, Ostfeld RJ Front Nutr, 2019. PMID 31245377

2019 / Narrative review

A 2% absolute increase in energy intake from trans fats is associated with a 23% increase in cardiovascular risk, alongside increased cancer and diabetes risk.

A review of epidemiologic and biochemical evidence evaluated trans fatty acid (TFA) intake and chronic disease risks. A 2% absolute increase in energy intake from trans fat has been associated with a 23% increase in cardiovascular risk. TFAs increase low-density lipoprotein levels, and several epidemiological studies demonstrate that high TFA intake increases the incidence of cancer and diabetes. Complete elimination of TFAs is not possible in a balanced diet due to their natural presence in dairy and meat products.

Shows an association, not proof of cause and effect.

Islam MA, Amin MN, Siddiqui SA, et al. Diabetes Metab Syndr, 2019. PMID 31336535

2019 / Narrative review

Animal protein intake increases insulin resistance, whereas plant-based foods improve insulin sensitivity and lower diabetes risk.

This review evaluates the effect of diet composition on insulin sensitivity and disease risk. Prospective studies indicate that diets high in animal products and low in plant foods increase the risk of type 2 diabetes and cardiovascular disease. In healthy individuals and patients with diabetes, animal protein intake worsens insulin resistance independently of BMI, whereas plant foods enhance insulin sensitivity. Additionally, pre-pregnancy meat intake is strongly linked to higher gestational diabetes risk, while pre-pregnancy vegetable protein is associated with lower risk. Diets restricting carbohydrates while increasing animal protein worsen insulin resistance even after weight loss.

Adeva-Andany MM, González-Lucán M, Fernández-Fernández C, et al. Clin Nutr ESPEN, 2019. PMID 31451269

2019 / Perspective / narrative review

A commentary outlines why a whole-foods, plant-based diet could address lifestyle-related chronic diseases, health care costs, and physician burnout.

This commentary discusses the unsustainable rise in US health care costs since the 1980s, noting that over 70% of health care dollars address the consequences of unhealthy lifestyles tied to obesity, diabetes, and cardiovascular disease. The author also notes an epidemic of physician burnout in the US. Based on these challenges, the author presents the perspective that a whole-foods, plant-based diet may support health, health care sustainability, and physician wellness.

Ha B Perm J, 2019. PMID 31496505

2019 / Perspective / narrative commentary

Education programs for physicians and patients on plant-based diets received an overwhelmingly positive response.

Obesity is a major risk factor for type 2 diabetes and cardiovascular disease, conditions that can be prevented and treated with nutritional interventions involving plant-based diets. Although many patients look to doctors for dietary advice, most physicians lack adequate nutrition education to provide meaningful guidance. Educational programs launched for physicians and patients regarding the benefits of plant-based diets received an overwhelmingly positive response.

Rahman V Perm J, 2019. PMID 31496507

2019 / Narrative review

A review notes recent vegetarian diet studies show risk reductions for cardiovascular, cerebrovascular, diabetes, and chronic kidney disease mortality.

This review evaluated the current prevalence, health benefits, and health risks associated with vegetarian diets. Compared to the Adventist Health Study 2, more recent prospective studies have demonstrated significant although smaller risk reductions for mortality in cardiovascular disease, cerebrovascular disease, diabetes mellitus, and chronic kidney disease. The review also notes potential health risks including deficiencies in protein, omega-3 fatty acids, vitamin D, vitamin B12, iron, calcium, and zinc.

Shows an association, not proof of cause and effect.

Rocha JP, Laster J, Parag B, et al. Curr Nutr Rep, 2019. PMID 31705483

2019 / Narrative review

Healthy plant-based diets are linked to lower risks of obesity, type 2 diabetes, cardiovascular disease, and certain cancers compared with Western diets.

This review discusses the intertwined burdens of diet-related chronic diseases and environmental degradation caused by current global dietary patterns and food systems. Shifting toward healthy plant-based diets, compared with typical Western diets high in animal products, has been associated with lower risks of obesity, type 2 diabetes, cardiovascular disease, and some cancers, while also improving sustainability. While precision nutrition may offer tailored disease prevention, it is in its early stages and not ready for widespread clinical use, underscoring the ongoing importance of broader public health nutrition strategies.

Shows an association, not proof of cause and effect.

Hemler EC, Hu FB Adv Nutr, 2019. PMID 31728495

2019 / Editorial

An editorial advocates for a strengths-based messaging approach to physical activity to enhance self-empowerment, hope, and health.

This editorial discusses messaging surrounding routine physical activity and exercise in the prevention of cardiovascular disease and other chronic conditions. The authors argue that conventional deficits-based messaging focused on inactivity risks and rigid thresholds misses opportunities to foster change. Instead, they propose a strengths-based approach focused on innate capabilities to build hope, promote the positive aspects of exercise, and support self-determination.

Warburton DER, Bredin SSD J Clin Med, 2019. PMID 31766502

2019 / Narrative review

A review suggests plant-based diets may reduce the risk of heart disease and possibly cancer among Black individuals in the United States.

This review evaluated the evidence on plant-based diets and health outcomes, examining how these benefits translate to Black individuals in the United States. Although substantial evidence supports plant-based diets in the general population, little research has focused specifically on Black populations. Available data suggest that plant-based diets may reduce the risk of heart disease and possibly cancer in this group. The authors note that more research is needed on cardiovascular risk factors, cancer subtypes, and other chronic diseases, emphasizing the need for culturally appropriate interventions.

Shows an association, not proof of cause and effect.

Sterling SR, Bowen SA Nutrients, 2019. PMID 31810250

2019 / Updated systematic review of meta-analyses

Nut consumption was linked to lower CVD, CHD, and stroke mortality/incidence, and reduced fasting glucose, total cholesterol, and LDL-C in meta-analyses.

An updated electronic search of PubMed/MEDLINE, CINAHL, and Cochrane Library identified seven new meta-analyses examining nut consumption and cardiometabolic diseases. Comparing high with low consumption categories, nut intake significantly decreased CVD mortality (-19% to -25%; n = 4), CHD mortality (-24% to -30%; n = 3), stroke mortality (-17% to -18%; n = 3), CVD incidence (-15% to -19%; n = 4), CHD/CAD incidence (-17% to -34%; n = 8), and stroke incidence (-10% to -11%; n = 6). Compared with control diets, nut consumption significantly reduced fasting glucose (0.08 to 0.15 mmol/L; n = 6), total cholesterol (0.021 to 0.30 mmol/L; n = 10), and LDL-C (0.017 to 0.26 mmol/L; n = 10). Body weight and blood pressure were not significantly affected.

Shows an association, not proof of cause and effect.

Kim Y, Keogh JB, Clifton PM Int J Environ Res Public Health, 2019. PMID 31817639

2019 / Narrative review

A review suggests that a plant-based diet may serve as a valuable tool for managing atrial fibrillation risk factors.

Atrial fibrillation affects an estimated 34 million individuals globally and carries a significant burden of morbidity and mortality. This review examines evidence regarding the use of a whole-food plant-based diet—emphasizing grains, legumes, vegetables, fruits, and nuts while excluding most or all animal products—for managing atrial fibrillation risk factors. It highlights effects on cardiovascular and metabolic factors including hypertension, coronary artery disease, diabetes, obesity, inflammation, and subclinical atherosclerosis.

Storz MA, Helle P J Arrhythm, 2019. PMID 31844466

2019 / Narrative review

Dietary advanced glycation end products are linked to metabolic diseases, aging, polycystic ovary syndrome, and infant health hazards.

This review describes the formation of advanced glycation end products (AGEs) during high-temperature cooking and their pathophysiological associations. Glycated Maillard products are linked to type 2 diabetes, acute renal failure, Alzheimer's disease, dental health, allergies, and polycystic ovary syndrome (PCOS). In diabetes, high levels of AGEs correlate with carotid thickening, ischemic heart disease, uremic cardiomyopathy, and kidney failure. Furthermore, infant formula milk is identified as a rich source of primary adducts like carboxy-methyl lysine, potentially rendering infants prone to inflammation, dementia, and food allergies.

Shows an association, not proof of cause and effect.

Gill V, Kumar V, Singh K, et al. Biomolecules, 2019. PMID 31861217

2018 / Review

Berry anthocyanin data show potential cardiovascular benefits, but longer-term randomised controlled trials are lacking.

Over half of cardiovascular events could be prevented by improved diet, and prospective studies supported by randomized controlled trials suggest fruit and vegetable benefits may stem from flavonoids such as anthocyanins. However, proof of efficacy from longer-term randomized controlled trials and an understanding of differential metabolism are distinctly lacking. The review notes that simple dietary change, including incorporating a few portions of anthocyanin-rich fruit, could have a significant impact at a public health level.

Cassidy A Mol Aspects Med, 2018. PMID 28483533

2018 / Narrative review / commentary

A healthy lifestyle including diet could prevent approximately 80% of chronic disease and premature death.

This article discusses the role of lifestyle choices in health and chronic disease prevention. It notes that approximately 80% of chronic disease and premature death could be prevented by avoiding smoking, engaging in physical activity, and following a healthful dietary pattern. Cardiovascular disease, diabetes, stroke, dementia, and cancer are all influenced by lifestyle. The author argues for a global coalition of experts to clarify confusing nutrition messages and promote health-promoting diet and lifestyle patterns.

Katz DL, Frates EP, Bonnet JP, et al. Am J Health Promot, 2018. PMID 28523941